Hyperglycaemia: The bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 12, Issue 1, 1999, Pages 42-46

  Ceriello, Antonio ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Diabetic complications; Hyperglycaemia; Non enzymatic glycation; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ENZYME; FREE RADICAL; GLYCOSYLATED PROTEIN;

CLINICAL FEATURE; COMPLICATION; DIABETES MELLITUS; GLYCATION; HUMAN; HYPERGLYCEMIA; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW;

ASCORBIC ACID; DIABETES COMPLICATIONS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; OXIDATIVE STRESS; VITAMIN E;

EID: 0032835194     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. The Diabetes Control and Complications Trials (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
2. UKPDS: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853, 1998.
3. Ceriello A., Quatraro A., Giugliano D.: New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabetic Med. 9: 297-299, 1992.
4. Brownlee M., Cerami A., Vlassara H.: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321, 1988.
5. Monnier V.M., Vishwanath V., Frank K.E., Elmets C.A., Dauchot P., Kohn R.R.: Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N. Engl. J. Med. 314: 403-408, 1986.
6. Dominiczak M.H., Bell J., Cox N.H., McCruden D., Jones S.K., Finlay A.Y., Percy-Robb I.W., Frier B.M.: Collagen-linked fluorescence is increased in the skin of young patients with type I (insulin-dependent) diabetes mellitus. Diabetes Care 13: 468-472, 1990.
7. Ceriello A.: Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36: 1119-1125, 1993.
8. Villanueva G.B., Allen N.: Demonstration of altered antithrombin III activity due to non enzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients. Diabetes 37: 1103-1107, 1988.
9. Ceriello A., Dello Russo P., Zuccotti C., Florio A., Nazzaro S., Pietrantuono C., Rosato G.B.: Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation. A preliminary report. Thromb. Haemostas. 50: 633-634, 1983.
10. Ceriello A., Giugliano D., Quatraro A., Consoli G., Stante A., Dello Russo P., D'Onofrio F.: Induced hyperglycaemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes 36: 320-323, 1987.
11. Ceriello A., Giugliano D., Quatraro A., Stante A., Consoli G., Dello Russo P., D'Onofrio F.: Heparin preserves antithrombin III biological activity from hyperglycaemia-induced alterations in insulin-dependent diabetics. Haemostasis 16: 458-464, 1986.
12. Ceriello A., Marchi E., Palazzini E., Quatraro A., Giugliano D.: Low molecular weight heparin restores antithrombin III activity from hyperglycaemia induced alterations. Diabete Metabol. 16: 86-92, 1990.
13. Ceriello A., Marchi E., Barbanti M., Milani M.R., Giugliano D., Quatraro A., Lefèbvre P.J.: Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. Diabetologia 33: 205-207, 1990.
14. Brownlee M., Vlassara H., Cerami A.: Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin. Diabetes 32: 600-604, 1983.
15. Winocour P.D., Watala C., Kinlough-Rathbone R.L.: Membrane fuidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospolipid molar ratio in isolated platelet membranes from diabetic and control subjects. Thromb. Haemostas. 65: 567-571, 1992.
16. Bryszewska M., Szosland K.: Association between the glycation of erythrocyte membrane proteins and membrane fluidity. Clin. Biochem. 21: 49-51, 1988.
17. Esposito C., Gerlach H., Brett J., Stern D., Vlassara H.: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J. Exp. Med. 170: 1387-1407, 1989.
18. Finot P.A.: Nonenzymatic browning products: physiologic effects and metabolic transit in relation to chemical structure: a review. Diabetes 31 (Suppl. 3): 22-28, 1982.
19. Hunt S.V., Dean R.T., Wolff S.P.: Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J. 256: 205-212, 1988.
20. Stolba P., Hatle K., Krnakova A., Streda M., Starka L.: Effects of ascorbic acid on nonenzymatic glycation of serum proteins in vitro and in vivo. Diabetologia 30: 529, 1987. (Abstract)
21. Stolba P., Streda M., Vondra K., Hatle K., Adam M.: Ascorbic acid inhibits non enzymatic glycation of collagen type I, IV, IX, XI, in vitro and renal basement membrane in vivo. Diabetologia 31: 546, 1988. (Abstract)
22. Ceriello A., Giugliano D., Quatraro A., Dello Russo P., Torella R.: A preliminary note on inhibiting effect of alpha-tocopherol (vitamin E) on protein glycation. Diabete Metab. 14: 40-42, 1988.
23. Ceriello A., Giugliano D., Quatraro A., Donzella C., Dipalo G., Lefèbvre P.J.: Vitamin E reduction of protein glycosylation in diabetes. New prospect for the prevention of diabetic complications? Diabetes Care 14: 68-72, 1991.
24. Jones A.F., Winkles J.W., Thornalley P.J., Lunec J., Jennings P.E., Barnett A.H.: Inhibitory effect of superoxide dismutase on fructosamine assay. Clin. Chem. 33: 147-149, 1987.
25. Gillery P., Monboisse J.C., Maquart F.X., Borel J.P.: Glycation of proteins as a source of superoxide. Diabete Metab. 14: 25-30, 1988.
26. Sakurai T., Tsuchiya S.: Superoxide production from nonenzymatically glycated proteins. FEBB Letters 236: 406-410, 1988.
27. Azevedo M., Falcao J., Raposo J., Manso C.: Superoxide radical generation by Amadori compound. Free Rad. Res. Commun. 4: 331-335, 1988.
28. Le Guen C.A., Bain S., Barnett A.H., Lunec J.: Captopril inhibits fluorescence development in non-enzymatically glycosylated proteins. Diabetologia 33: 140, 1990. (Abstract)
29. Baynes J.W.: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
30. Giugliano D., Ceriello A., Paolisso G.: Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996.
31. nd ed. John Wiley & Sons, Chichester, 1997, pp. 1453-1461.
32. Oberley L.W.: Free radicals and diabetes. Free Rad. Biol. Med. 5: 113-124, 1988.
33. Ceriello A., Bortolotti N., Falleti E., Taboga C., Tonutti L., Crescentini A., Motz E., Lizzio S., Russo A., Bartoli E.: Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care 20: 194-197, 1997.
34. Sato Y., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., Yagi K.: Lipid peroxide level in serum of diabetic patients. Biochem. Med. 21: 104-107, 1979.
35. Ceriello A., Giugliano D., Quatraro A., Dello Russo P., Lefèbvre P.J.: Metabolic control may influence the increased superoxide anion generation in diabetic serum. Diabetic Med. 8: 540-542, 1991.
36. Ceriello A., Quatraro A., Caretta F., Varano F., Giugliano D.: Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin-dependent diabetes. Diabete Metab. 16: 318-322, 1990.
37. Ceriello A., Giugliano D., Quatraro A., Lefèbvre P.J.: Antioxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin. Sci. 81: 739-742, 1991.
38. Ceriello A., Quatraro A., Giugliano D.: Diabetes mellitus and hypertension. The possible role of hyperglycaemia through oxidative stress. Diabetologia 36: 265-266, 1993.
39. Mullarkey C.J., Edelstein D., Brownlee M.: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173: 932-939, 1990.
40. Wolff S.P., Dean R.T.: Glucose auto-oxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem. J. 245: 243-250, 1987.
41. Ceriello A.: Acute hyperglycaemia and oxidative stress generation. Diabetic Med. 14: S45-S49, 1997.
42. Ceriello A., Bortolotti N., Crescentini A., Motz E., Lizzio S., Russo A., Ézsol Z., Tonutti L., Taboga C.: Antioxidant defenses are reduced during oral glucose tolerance test in normal and non-insulin dependent diabetic subjects. Eur. J. Clin. Invest. 28: 329-333, 1998.
43. Ceriello A., Bortolotti N., Motz E., Crescentini A., Lizzio S., Russo A., Tonutti L., Taboga C.: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21: 1529-1533, 1998.
44. Marfella R., Verrazzo G., Acampora R., La Marca C., Giunta R., Lucarelli C., Paolisso G., Ceriello A., Giugliano D.: Glutathione reverses systemic hemodynamic changes by acute hyperglycaemia in healthy subjects. Am. J. Physiol. 268: E1167-E1173, 1995.
45. Ceriello A., Motz E., Cavarape A., Lizzio S., Russo A., Quatraro A., Giugliano D.: Hyperglycaemia counterbalances the anti-hypertensive effect of glutathione in diabetic patients. Evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus. J. Diab. Compl. 11: 250-255, 1997.
46. Ceriello A.: Vitamin C and endothelial dysfunction: what is new? Circulation, in press.
47. Ceriello A., Giacomello R., Stel G., Motz E., Taboga C., Tonutti L., Pirisi M., Falleti E., Bartoli E.: Hyperglycaemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 44: 924-928, 1995.
48. Ceriello A., Falleti E., Motz E., Taboga C., Tonutti L., Ezsol Z., Gonano F., Bartoli E.: Hyperglycaemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm. Metab. Res. 30: 146-149, 1998.
49. Curcio F., Ceriello A.: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanism of diabetic vascular complications. In Vitro 28: 787-790, 1992.
50. Curcio F., Pegoraro I., Dello Russo P., Falleti E., Perrella G., Ceriello A.: SOD and GSH inhibit the high glucose-induced oxidative damage and the PDGF increased secretion in cultured human endothelial cells. Thromb. Haemostas. 74: 969-973, 1995.
51. Ceriello A., Curcio F., Dello Russo P., Pegoraro I., Stel G., Amstad P., Cerutti P.: The defence agianst free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production. Blood Coag. Fibrinolysis 6: 133-137, 1995.
52. Ceriello A., Dello Russo P., Amstad P., Cerutti P.: High glucose induces antioxidant defence in endothelial cell in culture. Evidence linking hyperglycaemia and oxidative stress. Diabetes 45: 471-477, 1996.
53. Sechi L.A., Ceriello A., Griffin C.A., Catena C., Amstad P., Schambelan M., Bartoli E.: Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 40: 23-29, 1997.
54. Ceriello A., Giugliano D., Quatraro A., D'Onofrio F.: Does a common mechanism induce the diverse complications of diabetes? Diabetes Care 11: 372-373, 1988.